Cinnamon (Ceylon vs Cassia)

Cinnamomum verum (Ceylon) / Cinnamomum cassia (Cassia)
Evidence Level
Moderate
2 Clinical Trials
5 Documented Benefits
3/5 Evidence Score

Cinnamon is the dried inner bark of Cinnamomum trees — two main supplement species: CEYLON (C. verum, 'true cinnamon', sweeter, lower coumarin) and CASSIA (C. cassia, more common in supplements and grocery stores, higher coumarin). Used for blood sugar/diabetes support. CRITICAL DISTINCTION: cassia cinnamon has HIGH COUMARIN content that can cause HEPATOTOXICITY at high chronic doses — Ceylon is preferred for supplemental/medicinal use.

Studied Dose 1-6 g/day cinnamon powder; 250-500 mg/day water-soluble extract (Cinnulin PF® standardized); typically 1-2 g daily
Active Compound Cinnamaldehyde, cinnamic acid, MHCP (methyl hydroxychalcone polymer), procyanidins; coumarin (in cassia)

Benefits

Modest Blood Glucose Reduction (T2DM)

Multiple meta-analyses show cinnamon (1-6 g/day) modestly reduces fasting glucose (~10-29 mg/dL) and HbA1c in T2DM patients. Effect is modest and inconsistent across trials. Standard diabetes management (metformin, lifestyle, GLP-1 agonists) remains foundational.

Insulin Sensitivity Improvement

Cinnamon may modestly improve insulin sensitivity via multiple mechanisms — most studied in metabolic syndrome and prediabetes contexts. MHCP compound shown to mimic insulin in vitro. Human translation modest.

Lipid Modest Improvement

Some trials show cinnamon reduces total cholesterol and LDL modestly. Effect inconsistent and substantially weaker than statins or other evidence-based lipid agents.

Antimicrobial / Anti-Fungal

Cinnamaldehyde has broad antimicrobial activity — used in oral care products, food preservation. Topical/oral use modest evidence for oral health.

Anti-Inflammatory / Antioxidant

Procyanidins and other polyphenols in cinnamon have antioxidant activity. Modest anti-inflammatory effects in some markers.

Mechanism of action

1

Insulin-Mimetic / Sensitizing Effects

MHCP (methyl hydroxychalcone polymer) and other cinnamon compounds activate insulin receptor and downstream signaling — modestly mimicking insulin and improving sensitivity. Animal evidence stronger than human.

2

Glucose Transporter Effects

Cinnamon may enhance glucose uptake into peripheral tissues via GLUT4 modulation — similar mechanism to exercise and insulin. Modest effect.

3

Alpha-Glucosidase Inhibition

Cinnamon polyphenols modestly inhibit intestinal alpha-glucosidase — reducing post-prandial glucose spikes. Similar mechanism to acarbose (prescription diabetes drug).

4

Coumarin Hepatotoxicity (Cassia)

Cassia cinnamon contains COUMARIN at levels (5,000-10,000 mg/kg dry weight) that can cause hepatotoxicity at chronic high doses. Ceylon cinnamon contains <250 mg/kg coumarin. EFSA TDI for coumarin: 0.1 mg/kg body weight/day. Heavy daily Cassia consumption (1-2 tsp+ daily) can exceed safe coumarin intake.

Clinical trials

1
Cinnamon for Type 2 Diabetes — Allen 2013 Meta-Analysis
PubMed

Meta-analysis of cinnamon (various forms and doses) for T2DM glycemic control.

Pooled across T2DM RCTs.

Cinnamon modestly reduced fasting glucose (~24 mg/dL), total cholesterol, LDL. Effect on HbA1c modest and not consistent. Effect size smaller than metformin or other established diabetes therapies.

2
Cinnamon for Glycemic Control — Costello 2016 Cochrane-Style Review
PubMed

Systematic review of cinnamon supplementation for T2DM — Costello et al. 2016.

Pooled across T2DM RCTs.

Modest glycemic effects across trials but high heterogeneity. Some trials positive, others negative. Standard T2DM management primary; cinnamon adjunctive at most.

Side effects and drug interactions

Common Potential side effects

GI distress (heartburn, nausea, mouth/lip irritation).
MOUTH SORES / oral irritation — particularly with 'cinnamon challenge' or high cinnamon contact.
HEPATOTOXICITY from CASSIA cinnamon's COUMARIN content — chronic high doses (>1-2 tsp daily); reversible if discontinued.
Allergic reactions / contact dermatitis.
Hypoglycemia in diabetics on insulin/sulfonylureas.
Bleeding risk at high doses (theoretical; cinnamon has mild antiplatelet effects).
Theobromine-like stimulating effects in some sensitive individuals.

Important Drug interactions

Diabetes medications (metformin, insulin, sulfonylureas) — additive hypoglycemic effects; monitor blood glucose.
Anticoagulants — modest theoretical bleeding risk at high doses; monitor.
Hepatotoxic drugs — additive liver toxicity risk with chronic high-dose Cassia.
CYP-metabolized drugs — cinnamon may modestly affect CYP enzymes; theoretical interactions.
Antihypertensives — possible additive BP reduction.

Frequently asked questions about Cinnamon (Ceylon vs Cassia)

What is Cinnamon (Ceylon vs Cassia)?

Cinnamon is the dried inner bark of Cinnamomum trees — two main supplement species: CEYLON (C.

What does Cinnamon (Ceylon vs Cassia) do?

MHCP (methyl hydroxychalcone polymer) and other cinnamon compounds activate insulin receptor and downstream signaling — modestly mimicking insulin and improving sensitivity. Animal evidence stronger than human. In clinical research, Cinnamon (Ceylon vs Cassia) has been studied for modest blood glucose reduction (t2dm), insulin sensitivity improvement, lipid modest improvement.

Who should take Cinnamon (Ceylon vs Cassia)?

Cinnamon (Ceylon vs Cassia) may be most relevant for people interested in metabolic health, anti-inflammatory. It has been clinically studied for modest blood glucose reduction (t2dm), insulin sensitivity improvement, lipid modest improvement. As with any supplement, consult your healthcare provider before starting, especially if you have medical conditions or take prescription medications.

How long does Cinnamon (Ceylon vs Cassia) take to work?

Most clinical trial effects appear over weeks of consistent use; individual response varies. Acute or same-day effects (where applicable) typically appear within hours, but most cumulative benefits — particularly those affecting biomarkers, mood, sleep quality, or chronic symptoms — require 4-12 weeks of regular use to fully assess. If you don't notice benefit after 12 weeks at the appropriate dose, it may not be your responder.

When is the best time to take Cinnamon (Ceylon vs Cassia)?

For cardiovascular or metabolic goals, Cinnamon (Ceylon vs Cassia) is typically taken with meals to support absorption and reduce GI sensitivity. Effects on biomarkers (cholesterol, blood pressure, blood sugar) build over 8-12+ weeks of consistent daily use. Always check product labeling and follow personalized guidance from your healthcare provider.

Is Cinnamon (Ceylon vs Cassia) worth taking?

Cinnamon (Ceylon vs Cassia) has moderate clinical evidence (Evidence Level 3/5 on NutraSmarts) — meaningful trial support exists, though results are less consistent than top-tier ingredients. Whether it's worth taking depends on your specific goals, what you've already tried, your budget, and your overall supplement strategy. The honest framing: no supplement is essential for most people, and lifestyle factors (sleep, exercise, diet, stress management) typically produce larger effects than any single supplement. Cinnamon (Ceylon vs Cassia) is most worth trying if its evidence-supported uses align with your specific goals.

What is the recommended dosage of Cinnamon (Ceylon vs Cassia)?

The clinically studied dose for Cinnamon (Ceylon vs Cassia) is 1-6 g/day cinnamon powder; 250-500 mg/day water-soluble extract (Cinnulin PF® standardized); typically 1-2 g daily. Always follow product labeling and consult a healthcare provider for personalized dosing recommendations.

What is Cinnamon (Ceylon vs Cassia) used for?

Cinnamon (Ceylon vs Cassia) is studied for modest blood glucose reduction (t2dm), insulin sensitivity improvement, lipid modest improvement. Multiple meta-analyses show cinnamon (1-6 g/day) modestly reduces fasting glucose (~10-29 mg/dL) and HbA1c in T2DM patients. Effect is modest and inconsistent across trials.